Myovant Sciences Ltd. MYOV

$ 26.98 -0.04%

Quarterly report 2022-Q4
added 01-26-2023

Myovant Sciences Ltd. Balance Sheet 2011-2024 | MYOV

Annual Balance Sheet Myovant Sciences Ltd.

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-663 M	40.1 M	-56.7 M	-65 M	-181 M	-	-	-	-	-	-
Long Term Debt	9.19 M	114 M	93.2 M	43.6 M	-	-	-	-	-	-	-
Long Term Debt Current	1.81 M	1.52 M	6.14 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	128 M	96.7 M	44.3 M	165 K	-	-	-	-	-	-
Total Current Liabilities	281 M	85.9 M	72 M	37.1 M	18.3 M	-	-	-	-	-	-
Total Liabilities	1.08 B	214 M	169 M	81.4 M	18.5 M	223 K	-	-	-	-	-
Deferred Revenue	-	40 M	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.05 B	-791 M	-502 M	-228 M	-85.1 M	-1.66 M	-	-	-	-	-
Total Assets	725 M	106 M	173 M	119 M	185 M	-	-	-	-	-	-
Cash and Cash Equivalents	674 M	76.6 M	156 M	109 M	181 M	-	-	-	-	-	-
Book Value	-354 M	-108 M	4.33 M	37.7 M	167 M	-223 K	-	-	-	-	-
Total Shareholders Equity	-354 M	-108 M	4.33 M	37.7 M	167 M	-223 K	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Myovant Sciences Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	5.48 M	5.79 M	-	7.04 M	7.62 M	8.16 M	8.68 M	9.19 M	9.67 M	10.1 M	10.6 M	-	-	92.1 M	89.1 M	93.2 M	97.2 M	43.6 M	44.1 M	43.6 M	28.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	962 M	997 M	-	993 M	1.04 B	1.06 B	1.13 B	1.08 B	1.04 B	336 M	261 M	214 M	178 M	167 M	171 M	169 M	155 M	94.1 M	94.2 M	81.4 M	55.8 M	17.4 M	17.4 M	18.5 M	7.99 M	39.9 M	-	223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	117 M	117 M	-	101 M	101 M	101 M	117 M	101 M	101 M	-	-	40 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.38 B	-1.32 B	-	-1.25 B	-1.19 B	-1.13 B	-1.11 B	-1.05 B	-965 M	-891 M	-824 M	-791 M	-726 M	-640 M	-570 M	-502 M	-427 M	-356 M	-291 M	-228 M	-180 M	-138 M	-109 M	-85.1 M	-63.4 M	-55.3 M	-	-1.66 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	404 M	484 M	-	520 M	604 M	680 M	728 M	725 M	774 M	136 M	127 M	106 M	130 M	184 M	251 M	173 M	202 M	168 M	154 M	119 M	138 M	136 M	163 M	185 M	194 M	2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	251 M	342 M	-	407 M	458 M	518 M	485 M	674 M	714 M	714 M	94.2 M	84.7 M	83.1 M	83.1 M	130 M	227 M	183 M	183 M	154 M	109 M	129 M	129 M	154 M	181 M	192 M	73 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-558 M	-513 M	-	-473 M	-432 M	-383 M	-400 M	-354 M	-271 M	-200 M	-135 M	-108 M	-48.9 M	17.3 M	79.6 M	4.33 M	46.7 M	74.1 M	60.2 M	37.7 M	82.2 M	119 M	146 M	167 M	186 M	-37.9 M	-	-223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-558 M	-513 M	-484 M	-473 M	-432 M	-383 M	-400 M	-400 M	-271 M	-271 M	-200 M	-135 M	-48.9 M	-48.9 M	17.3 M	79.6 M	46.7 M	46.7 M	74.1 M	37.7 M	82.2 M	119 M	146 M	167 M	186 M	-37.9 M	-	-223 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency